Since their first agreement in 2010, SomaLogic and NEC have worked to establish a long-term strategic relationship between the companies to integrate NEC's information technology as an enhancement of SomaLogic's products for life sciences research, drug discovery and development, and diagnostics. SomaSuite is the first product developed under this agreement, and it is now included as a part of the SOMAscan assay service.
SomaSuite is a stand-alone, Windows-based software tool designed for simplicity and usability. It features a workflow-driven interface that guides the user from raw data to results, including:
- Rapid grouping (and re-grouping) of samples for easy user-generated comparisons;
- Tests to identify difference in protein response (or differential protein regulation) between groups of samples;
- Visualization of results in a variety of formats;
- Selection of proteins of interest identified during the analysis steps.
"We undertook this collaboration with SomaLogic to leverage the unique strengths of both companies for the purpose of optimizing the use of protein biomarkers to provide better healthcare, and thus to enhance people's lives worldwide," said Takuya Yamaguchi, General Manager of NEC's Medical Solutions Division. "Providing quick and direct access to results from the powerful protein biomarker platform is an important step towards realizing that shared goal."
Provided by SomaLogic, Inc.
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.